Form D · Biotechnology

PEPTINOVO BIOPHARMA INC.

Ann Arbor, MI · CIK 0001868564

Offering snapshot reported Dec 16, 2024 · SEC filing

Reported sold
$1.3M
Offering amount: $10M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 10, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$659K$1.32MSep 24, 2024: $1,318,700.00Sep 24, 2024Dec 16, 2024: $1,297,885.00Dec 16, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,318,700 → $1,297,885

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 16, 2024Amendment$1,297,885-$20,815vs Sep 24, 202412SEC filing
Sep 24, 2024Initial$1,318,700No comparison12SEC filing
Jun 21, 2021Initial$955,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-524776

Source: Form D, filed Dec 16, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fred Brown Director
Bill Elliott Executive
Reynold Homan Director, Executive
David Romenesco Director
Steve Tokaz Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
600 S. Wagner Road
Ann Arbor, MI, 48103